BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26960405)

  • 1. Harmful excipients in medicines for neonates in Spain.
    Garcia-Palop B; Movilla Polanco E; Cañete Ramirez C; Cabañas Poy MJ
    Int J Clin Pharm; 2016 Apr; 38(2):238-42. PubMed ID: 26960405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical Excipient Exposure in a Neonatal Intensive Care Unit.
    Nasrollahi S; Meera NK; Boregowda S
    Indian Pediatr; 2020 Sep; 57(9):801-804. PubMed ID: 32999107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cumulative Daily Tolerance Levels of Potentially Toxic Excipients Ethanol and Propylene Glycol Are Commonly Exceeded in Neonates and Infants.
    Valeur KS; Hertel SA; Lundstrøm KE; Holst H
    Basic Clin Pharmacol Toxicol; 2018 May; 122(5):523-530. PubMed ID: 29281181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospitalised neonates in Estonia commonly receive potentially harmful excipients.
    Lass J; Naelapää K; Shah U; Käär R; Varendi H; Turner MA; Lutsar I
    BMC Pediatr; 2012 Aug; 12():136. PubMed ID: 22931304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible effects of excipients used in the parenteral drugs administered in critically ill adults, children, and neonates.
    Sridharan K; Hasan HM; Al Jufairi M; Al Daylami A; Al Ansari E; Qader AM; Pasha SAA
    Expert Opin Drug Saf; 2020 Dec; 19(12):1625-1640. PubMed ID: 32767900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentially harmful excipients in neonatal medicines: a pan-European observational study.
    Nellis G; Metsvaht T; Varendi H; Toompere K; Lass J; Mesek I; Nunn AJ; Turner MA; Lutsar I;
    Arch Dis Child; 2015 Jul; 100(7):694-9. PubMed ID: 25854872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safe excipient exposure in neonates and small children - protocol for the SEEN project.
    Valeur KS; Hertel SA; Lundstrøm KE; Holst H
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and pattern of pharmaceutical and excipient exposure in a neonatal unit in Slovenia.
    Fister P; Urh S; Karner A; Krzan M; Paro-Panjan D
    J Matern Fetal Neonatal Med; 2015; 28(17):2053-61. PubMed ID: 25316561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentially harmful excipients in neonatal medications: a multicenter nationwide observational study in Japan.
    Saito J; Nadatani N; Setoguchi M; Nakao M; Kimura H; Sameshima M; Kobayashi K; Matsumoto H; Yoshikawa N; Yokoyama T; Takahashi H; Suenaga M; Watanabe R; Imai K; Obara M; Hashimoto M; Yamamoto K; Fujiwara N; Sakata W; Nagai H; Enokihara T; Katayama S; Takahashi Y; Araki M; Iino K; Akiyama N; Katsu H; Fushimi K; Takeda T; Torimoto M; Kishi R; Mitsuya N; Kihara R; Hasegawa Y; Hamada Y; Kimura T; Wada M; Tanzawa A; Yamatani A
    J Pharm Health Care Sci; 2021 Jul; 7(1):23. PubMed ID: 34193299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates.
    Shehab N; Lewis CL; Streetman DD; Donn SM
    Pediatr Crit Care Med; 2009 Mar; 10(2):256-9. PubMed ID: 19188870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective and observational analysis of harmful excipients in medicines for hospitalised neonates in Latvia.
    Sviestina I; Mozgis D
    Eur J Hosp Pharm; 2018 Jul; 25(4):176-182. PubMed ID: 31157015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment of neonatal excipient exposure: lessons from food safety and other areas.
    Turner MA; Duncan JC; Shah U; Metsvaht T; Varendi H; Nellis G; Lutsar I; Yakkundi S; McElnay JC; Pandya H; Mulla H; Vaconsin P; Storme T; Rieutord A; Nunn AJ
    Adv Drug Deliv Rev; 2014 Jun; 73():89-101. PubMed ID: 24239480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to potentially harmful excipients in medications among neonates at a state hospital in Malaysia.
    Wong SW; Chew SP; Abdul Aziz SA; Mohamed Shah N
    Drug Dev Ind Pharm; 2024 Mar; ():1-9. PubMed ID: 38459761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I).
    Golightly LK; Smolinske SS; Bennett ML; Sutherland EW; Rumack BH
    Med Toxicol Adverse Drug Exp; 1988; 3(2):128-65. PubMed ID: 3287089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-Appropriate Formulations Including Pharmaceutical Excipients in Neonatal Medicines.
    Kogermann K; Lass J; Nellis G; Metsvaht T; Lutsar I
    Curr Pharm Des; 2017; 23(38):5779-5789. PubMed ID: 28950820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excipient exposure in very low birth weight preterm neonates.
    Akinmboni TO; Davis NL; Falck AJ; Bearer CF; Mooney SM
    J Perinatol; 2018 Feb; 38(2):169-174. PubMed ID: 29095430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-label use and harmful potential of drugs in a NICU in Brazil: A descriptive study.
    de Souza AS; Dos Santos DB; Rey LC; Medeiros MG; Vieira MG; Coelho HLL
    BMC Pediatr; 2016 Jan; 16():13. PubMed ID: 26795213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potentially harmful excipients in prescribed medications in a Neonatal Intensive Care Unit in Kosovo and available safer alternatives.
    Koshi B; Grapci AD; Nebija D; Selmani PB; Morina R; Crcarevska MS; Dodov MG; Raichki RS
    Turk J Pediatr; 2022; 64(1):49-58. PubMed ID: 35286030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extra-phosphate intestinal load from medications: is it a real concern?
    Cupisti A; Moriconi D; D'Alessandro C; Verde F; Marchini M; Saba A; Egidi MF
    J Nephrol; 2016 Dec; 29(6):857-862. PubMed ID: 27084800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Investigation on Exposure to Potentially Harmful Excipients by Injection Drug Administration in Children Under 2 Years of Age and Analysis of Association with Adverse Events: A Single-Center, Retrospective Observational Study.
    Saito J; Nakamura H; Akabane M; Yamatani A
    Ther Innov Regul Sci; 2024 Mar; 58(2):316-335. PubMed ID: 38055156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.